Multiple Award IDIQ Construction Contract

National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR). To obtain a copy of the Sources Sought please click the following link: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr or email Leidos Biomedical Research POC: Contracts Manager, Matthew Hull @ matthew.hull@nih.gov Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. Leidos Biomedical Research, Inc. POC: Contracts Manager at matthew.hull@nih.gov For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr or contact the Leidos Biomedical Research Point of Contact listed in this announcement.

• NAICS236220

• SAM Request (Sources Sought) revised_8.13.2026.pdf

  .pdf142 KBNot yet available

• Matthew Hull
  matthew.hull@nih.gov